LIVE Grant Call
The latest call for funding applications has been announced: a joint grant from SRUK and WSF!
The SRUK and WSF Research Grant Programme 2021-2022
Scleroderma and Raynaud's UK (SRUK) is the only UK charity dedicated to improving the lives of people with scleroderma and Raynaud's phenomenon. We envision a world where no-one has their life limited by scleroderma and Raynaud's.
The World Scleroderma Foundation (WSF) promotes and supports global research into all aspects of scleroderma and is committed to improving the quality of life for scleroderma sufferers and their families.
SRUK and WSF are pleased to work together once again to promote innovative and high-quality research by new and established investigators in fields related to scleroderma.
Stratified Medicine of the Future
The focus of this joint call for grants is Stratified Medicine of the Future. Systemic sclerosis is a highly complex and heterogeneous condition in terms of clinical presentation, disease progression, organ involvement and patient outcomes. On an individual level, this complexity presents a challenge both in predicting disease progression and prognosis. This should ensure that patients have timely access to the most effective treatments before irreversible organ damage has occurred. On a wider level, the ability to stratify patients is therefore of intrinsic value in the design of clinical studies and trials to minimise ambiguity in treatment effects and demonstrate the efficacy of tailored treatments for SSc.
This ‘winner-takes-all’ award will pump-prime research into future methods of patient stratification, enabling the winner to develop preliminary data or concepts which could be used to support larger consortia-based applications.
Funding available: £100,000 GBP for 1 project
- The lead investigator must either hold a faculty or equivalent position and must demonstrate that they are best placed to pursue a career in scleroderma related research / or be a young investigator mentored by a tenured colleague.
- Projects must be collaborative involving a minimum of 2 scleroderma centres, one of which must be in the UK.
- The proposal must clearly delineate how the project outputs could be used to develop a patient stratification tool.
- Applicants / host institutions must be diligent in ensuring the signed terms and conditions are returned by the stated deadline. This is a condition of funding.
Grant Application Process
Step 1 – Expression of Interest - Deadline 1st September, 2021
- Expression of Interest Application to include:
- Completed 'letter of intent' form including short background, the aim, the objectives, the methods, the expected results and the potential patient benefits.
- The SRUK/WSF Expression of Interest Form can be found at the bottom of the page, and must be returned to the secure folder.
- Submission deadline is 1pm, Wednesday 1st September 2021.
- Eligibility: Applications may be submitted by non-profit organisations, public and private such as universities, colleagues, hospitals, and laboratories.
Successful outline applicants will be invited to progress to the next stage of the competition and are expected to receive notification by 1st October 2021.
Step 2 – Full Application - Deadline 12th November, 2021
- Completion of the SRUK/WSF full application form by invited applicants, including:
- Introduction/background, objectives, specific aims, methods, statistical analysis, expected results including potential problems, benefit for patients, further directions, lay summary for patients.
- Duration of the project
- List of participants with their letter of support
- COI statement
- CV of each participant
- Letter of recommendation.
- Submission deadline for invited full applications is 1pm, Wednesday 12th November 2021.
- The committee's decision will be communicated to the applicant by the 17th January 2022.
The winner will also be announced in the opening ceremony of the 7th Systemic Sclerosis World Congress 2022 and will be expected to deliver a brief overview of their proposed research.
The grant application process and grant award administration will be coordinated via the SRUK head office.
Please contact email@example.com in case of questions or issues with the application process.
Successful grants to commence no later than March 2022 with mandatory presentation of an abstract with preliminary or final results at the following World Scleroderma Congress.